What's in Kristine Patterson, MD's pipeline?

Kristine Patterson, MD has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Kristine Patterson, MD's portfolio?

Top competitors by shared drug class: ANRS, Emerging Infectious Diseases, Chang Gung Memorial Hospital, Danish HIV Research Group, French National Agency for Research on AIDS and Viral Hepatitis, Hospital Nossa Senhora da Conceicao.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/kristine-patterson-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Kristine Patterson, MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Kristine Patterson, MD pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Infectious Disease / Virology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ANRS, Emerging Infectious Diseases · 1 shared drug class
Chang Gung Memorial Hospital · 1 shared drug class
Danish HIV Research Group · 1 shared drug class
French National Agency for Research on AIDS and Viral Hepatitis · 1 shared drug class
Hospital Nossa Senhora da Conceicao · 1 shared drug class
PETHEMA Foundation · 1 shared drug class
University of Alberta · 1 shared drug class
University of North Carolina, Chapel Hill · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Kristine Patterson, MD:

Cite this brief

Drug Landscape (2026). Kristine Patterson, MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/kristine-patterson-md. Accessed 2026-05-16.